The skin's secret script: fingerprints of CD34 and the dolphin dance of Schwann cells

Authors

  • Vijay Joshi Department of Dermatology, Seth GSMC and KEM Hospital, Mumbai, Maharashtra, India
  • Ketki Bhoite Department of Dermatology, Seth GSMC and KEM Hospital, Mumbai, Maharashtra, India
  • Vidya Kharkar Department of Dermatology, Seth GSMC and KEM Hospital, Mumbai, Maharashtra, India
  • Rajiv Joshi Department of Dermatology, Seth GSMC and KEM Hospital, Mumbai, Maharashtra, India
  • Surupa Das Department of Dermatology, Seth GSMC and KEM Hospital, Mumbai, Maharashtra, India

DOI:

https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20253401

Keywords:

Segmental neurofibromatosis, Spindle cell tumour, S100, CD34, Immunohistochemistry

Abstract

Segmental neurofibromatosis (SNF), or Riccardi type V, is an uncommon mosaic variant of neurofibromatosis type 1, arising from postzygotic mutations in the NF1 gene. It reveals itself through dermatomally confined clusters of neurofibromas, usually in the absence of systemic features or family history. A 55-year-old woman presented with multiple, progressively enlarging papulonodular lesions localized to the left upper arm. Histopathological analysis demonstrated a non-encapsulated dermal spindle cell tumor with elongated, wavy, buckled nuclei-reminiscent of “diving dolphins”-set within a fibro-myxoid, mast cell-rich stroma. Immunohistochemistry further refined the picture: Schwann cells showed diffuse S100 positivity, while CD34 staining unveiled the delicate “fingerprint” pattern of dendritic fibroblasts. Taken together, these findings confirmed the diagnosis of neurofibroma. The segmental distribution and absence of systemic features established the diagnosis of SNF. The lesions were excised sequentially using elliptical incisions, leading to uneventful recovery and satisfactory cosmetic results. This case underscores the diagnostic value of correlating clinical distribution with distinctive microscopic clues. The dermatomal clustering of lesions, the evocative “diving dolphin” nuclei, and the CD34 fingerprint pattern together form a compelling diagnostic triad of SNF. Awareness of these features helps avoid misclassification among spindle cell tumours and ensures that management remains both accurate and tailored to patient needs.

Metrics

Metrics Loading ...

References

Sobjanek M, Dobosz-Kawałko M, Michajłowski I, Pęksa R, Nowicki R. Segmental neurofibromatosis. Postepy Dermatol Alergol. 2014;31(6):410-2. DOI: https://doi.org/10.5114/pdia.2014.40942

Gayathri A, Ramachandran R, Narasimhan M. Segmental neurofibromatosis with Lisch nodules. Med J Armed Forces India. 2023;79(3):356-9. DOI: https://doi.org/10.1016/j.mjafi.2020.11.021

Bajaj A. The Neural Pleonastics – Neurofibroma. J Clin Med Images. 2020;5(4):1-6.

Iswarya A, Vijayasankar P, Karthikeyan K, Sriram V. Segmental leiomyoma: a report of two cases. Turk J Dermatol. 2021;15(3):80-2. DOI: https://doi.org/10.4103/tjd.tjd_50_21

Englander L, Emer JJ, McClain D, Amin B, Turner RB. A rare case of multiple segmental eccrine spiradenomas. J Clin Aesthet Dermatol. 2011;4(4):38-44.

Bhabha FK, Magee J, Ng SY, Grills CE, Su J, Orchard D. Multiple clustered dermatofibroma presenting in a segmental distribution. Australas J Dermatol. 2016;57(1):e20-2. DOI: https://doi.org/10.1111/ajd.12257

Bosch F, Rosich L. The contributions of Paul Ehrlich to pharmacology: a tribute on the occasion of the centenary of his Nobel Prize. Pharmacology. 2008;82(3):171-9. DOI: https://doi.org/10.1159/000149583

Hong SP, Ahn SK. Abundant eosinophil infiltration in a neurofibroma. Am J Dermatopathol. 2007;29(2):187-9. DOI: https://doi.org/10.1097/DAD.0b013e318033275e

Nagrani NS, Bhawan J. Histopathological variants of cutaneous neurofibroma: a compendious review. Dermatopathology (Basel). 2022;10(1):1-19. DOI: https://doi.org/10.3390/dermatopathology10010001

Yeh I, McCalmont TH. Distinguishing neurofibroma from desmoplastic melanoma: the value of the CD34 fingerprint. J Cutan Pathol. 2011;38(8):625-30. DOI: https://doi.org/10.1111/j.1600-0560.2011.01700.x

Park JY, Park H, Park N, Park J, Sung HJ, Lee S. Use of calretinin, CD56, and CD34 for differential diagnosis of schwannoma and neurofibroma. Korean J Pathol. 2011;45(1):30-5. DOI: https://doi.org/10.4132/KoreanJPathol.2011.45.1.30

Ghosh PS, Ghosh D. Teaching NeuroImages: MRI “target sign” and neurofibromatosis type 1. Neurology. 2012;78(9):e63. DOI: https://doi.org/10.1212/WNL.0b013e318248df63

Klesse LJ, Jordan JT, Radtke HB, Rosser T, Schorry E, Ullrich N, et al. The use of MEK inhibitors in neurofibromatosis type 1-associated tumors and management of toxicities. Oncologist. 2020;25(7):e1109-16. DOI: https://doi.org/10.1634/theoncologist.2020-0069

Downloads

Published

2025-10-25

How to Cite

Joshi, V., Bhoite, K., Kharkar, V., Joshi, R., & Das, S. (2025). The skin’s secret script: fingerprints of CD34 and the dolphin dance of Schwann cells. International Journal of Research in Dermatology, 11(6), 541–545. https://doi.org/10.18203/issn.2455-4529.IntJResDermatol20253401